Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $14.48, for a total transaction of $434,400.00. Following the sale, the president now owns 2,072,899 shares of the company’s stock, valued at approximately $30,015,577.52. This represents a 1.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, May 14th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.87, for a total transaction of $446,100.00.
• On Monday, April 14th, Dawn Christine Maroney sold 230,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $19.10, for a total transaction of $4,393,000.00.
• On Thursday, March 27th, Dawn Christine Maroney sold 11,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.89, for a total value of $199,509.28.
• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.40, for a total value of $271,174.00.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $14.57 on Wednesday. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.69 and a quick ratio of 1.69. The company has a market cap of $2.88 billion, a price-to-earnings ratio of -30.35 and a beta of 1.22. The stock’s 50-day moving average is $16.20 and its two-hundred day moving average is $14.94. Alignment Healthcare, Inc. has a 1-year low of $7.05 and a 1-year high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 80.49% and a negative net margin of 3.02%. The business had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. During the same period in the previous year, the company posted ($0.25) earnings per share. The business’s revenue for the quarter was up 47.5% on a year-over-year basis. Analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ALHC. Wellington Management Group LLP increased its position in shares of Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in shares of Alignment Healthcare by 54.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock worth $97,302,000 after purchasing an additional 3,059,596 shares in the last quarter. Millennium Management LLC grew its stake in shares of Alignment Healthcare by 588.3% during the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock worth $38,122,000 after purchasing an additional 2,896,311 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Alignment Healthcare in the fourth quarter valued at $20,087,000. Finally, Invesco Ltd. raised its stake in Alignment Healthcare by 1,415.7% in the first quarter. Invesco Ltd. now owns 1,875,790 shares of the company’s stock valued at $34,927,000 after buying an additional 1,752,033 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on ALHC shares. Bank of America lifted their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a research note on Tuesday, March 4th. Stephens raised Alignment Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Piper Sandler boosted their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Finally, UBS Group lifted their price objective on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a “neutral” rating in a report on Friday, May 2nd. One analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $17.17.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.